Day: March 22, 2021

CNN3: ‘”}, “chartbeat”:{“sections”:””}, “branding_content_page”:”default”, “branding_content_zone”:[“default”, “branding_content_container”:”default”, “cnn-money-markets”, “space-and-science”, “branding_content_card”:””} , edition: “domestic” , sourceId: “‘]BANNER=|pagerendered| ((lubuntu at wor2 670N))

|| AstraZeneca vaccine 79% effective against symptomatic Covid ||”},”chartbeat”:{“sections”:””},”branding_content_page”:”default”,”branding_content_zone”:[“default”],”branding_content_container”:[“default”,”cnn-money-markets”,”space-and-science”],”branding_content_card”:[“”]} , edition: “domestic” , sourceId: “

CNN2: subjectpartBANNER=|AstraZeneca vaccine 79% effective against symptomatic Covid| ((lubuntu at wor2 670N)))

|| AstraZeneca vaccine 79% effective against symptomatic Covid ||The company announced the findings from the new Phase 3 trial, which included more than 32,000 participants and may boost confidence in the vaccine

CNN3: ‘”}, “chartbeat”:{“sections”:””}, “branding_content_page”:”default”, “branding_content_zone”:[“default”, “branding_content_container”:”default”, “cnn-money-markets”, “space-and-science”, “branding_content_card”:””} , edition: “domestic” , sourceId: “‘]BANNER=|pagerendered| ((lubuntu at wor2 1TXN))

|| AstraZeneca vaccine 79% effective against symptomatic Covid ||”},”chartbeat”:{“sections”:””},”branding_content_page”:”default”,”branding_content_zone”:[“default”],”branding_content_container”:[“default”,”cnn-money-markets”,”space-and-science”],”branding_content_card”:[“”]} , edition: “domestic” , sourceId: “

CNN2: subjectpartBANNER=|=”banner-text screaming-banner-text banner-text-size–char-47″ data-analytics=”_list-hierarchical-xs_article_”>AstraZeneca vaccine 79% effective against symptomatic Covid| ((lubuntu at wor2 1TXN)))

|| AstraZeneca vaccine 79% effective against symptomatic Covid ||=”banner-text screaming-banner-text banner-text-size–char-47″ data-analytics=”_list-hierarchical-xs_article_”>AstraZeneca vaccine 79% effective against symptomatic Covid

CNN3: ‘”}, “chartbeat”:{“sections”:””}, “branding_content_page”:”default”, “branding_content_zone”:[“default”, “branding_content_container”:”default”, “cnn-money-markets”, “space-and-science”, “branding_content_card”:””} , edition: “domestic” , sourceId: “‘]BANNER=|pagerendered| ((lubuntu at wor2 670N))

|| Experts are split over whether US is headed for another surge ||”},”chartbeat”:{“sections”:””},”branding_content_page”:”default”,”branding_content_zone”:[“default”],”branding_content_container”:[“default”,”cnn-money-markets”,”space-and-science”],”branding_content_card”:[“”]} , edition: “domestic” , sourceId: “

CNN2: subjectpartBANNER=|=”banner-text screaming-banner-text banner-text-size–char-47″ data-analytics=”_list-hierarchical-xs_article_”>AstraZeneca vaccine 79% effective against symptomatic Covid| ((lubuntu at wor2 670N)))

|| Experts are split over whether US is headed for another surge ||=”banner-text screaming-banner-text banner-text-size–char-47″ data-analytics=”_list-hierarchical-xs_article_”>AstraZeneca vaccine 79% effective against symptomatic Covid

nprnews_____ = ||| lubuntu at wor2 1TXN|||AstraZeneca Vaccine Is Effective Against COVID-19, Phase III Study Says||| kickerpage = |||no kicker pagenpr for NPRNEWS||| summarynpr = |||Results of the trial, which involved more than 32, 000 volunteers, showed two doses of the vaccine administered four weeks apart had an efficacy of 79% at preventing symptoms of COVID-19.

class=”imagewrap has-source-dimensions”
data-crop-type=”wide”
style=”
–source-width: 4101;
–source-height: 2306;
”
>

AstraZeneca Vaccine Is Effective Against COVID-19, Phase III Study Says

Results from a Phase III trial show the Oxford AstraZeneca COVID-19 vaccine can be 79% effective at preventing symptoms of COVID-19.

Finnbarr Webster/Getty Images


hide caption

toggle caption

Finnbarr Webster/Getty Images


The Coronavirus Crisis


AstraZeneca Vaccine Is Effective Against COVID-19, Phase III Study Says



Results of the trial, which involved more than 32,000 volunteers, showed two doses of the vaccine administered four weeks apart had an efficacy of 79% at preventing symptoms of COVID-19.


European Scientists Zero In On AstraZeneca Blood Clot Link

CNN3: ‘”}, “chartbeat”:{“sections”:””}, “branding_content_page”:”default”, “branding_content_zone”:[“default”, “branding_content_container”:”default”, “cnn-money-markets”, “space-and-science”, “branding_content_card”:””} , edition: “domestic” , sourceId: “‘]BANNER=|pagerendered| ((lubuntu at wor2 1TXN))

|| Experts are split over whether US is headed for another surge ||”},”chartbeat”:{“sections”:””},”branding_content_page”:”default”,”branding_content_zone”:[“default”],”branding_content_container”:[“default”,”cnn-money-markets”,”space-and-science”],”branding_content_card”:[“”]} , edition: “domestic” , sourceId: “

Design a site like this with WordPress.com
Get started